Healthcare and Technology news
51.5K views | +0 today
Healthcare and Technology news
Your new post is loading...
Your new post is loading...!

US expands air quality monitoring to include some embassies

US expands air quality monitoring to include some embassies | Healthcare and Technology news |

The United States plans to expand air quality monitoring at some U.S. embassies and consulates to help increase awareness on the dangers of pollution.

The initiative announced Wednesday by the State Department and the Environmental Protection Agency builds on a monitoring service begun five years ago at the U.S. Embassy in Beijing.

Secretary of State John Kerry says the service will expand to India, Vietnam, Mongolia and elsewhere.

He says the monitoring will provide information to U.S. foreign service officers, members of the military and Americans abroad, and help build international cooperation on curbing air pollution.

The information will be provided on an EPA website, AirNow — — that already has air monitors at nearly 4,000 locations in the United States.

No comment yet.!

Millions Of Americans Taking Aspirin When They Shouldn't

Millions Of Americans Taking Aspirin When They Shouldn't | Healthcare and Technology news |

More than a third of US adults– more than 50 million people– now take aspirin for the primary and secondary prevention of cardiovascular disease. (Primary prevention is the prevention of a first event; secondary prevention is the prevention of a recurrent event.) Although it was once broadly recommended, because of the increased risk of bleeding complications the use of aspirin for primary prevention of cardiovascular disease is now only indicated in people who have a moderate to high 10-year risk. (Aspirin is still broadly recommended for secondary prevention.) Now a new report  published in the Journal of the American College of Cardiology finds that there are still a significant number of people who are receiving aspirin inappropriately.

Different medical groups have various recommendations about the precise indications for aspirin for primary prevention, but there is broad agreement that aspirin is not appropriate in people who are at low risk, defined as a 10 year risk below 6%. Using data from more than 68,000 primary prevention patients receiving aspirin who were followed in the National Cardiovascular Disease Registry Practice Innovation and Clinical Excellence (PINNACLE) Registry, researchers calculated that 11.6% had a 10 year risk below 6%. Women were more likely than men to receive aspirin inappropriately. Inappropriate use varied significantly at the practice level, ranging from 7.2% in the lowest quartile to 13.6% in the upper quartile. People who received aspirin inappropriately were 16 years younger, on average, than people who received aspirin appropriately. Over time the rate of inappropriate use has declined, from 14.5% in 2008 to 9.1% in 2013.

“Our findings suggest that there are important opportunities to improve evidence-based use of aspirin for primary CVD prevention.” the authors concluded.

No comment yet.